FDA Approved: NELARABINE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved an original-application abbreviated new drug application for nelarabine from Novadoz Pharmaceuticals LLC, enabling the marketing of a generic n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)